Omalizumab for chronic urticaria in children younger than 12 yearsTaha Al‐Shaikhly, Daniel Petroni, Andrew G. Ayars et al.|Annals of Allergy Asthma & Immunology|2019Cited by 34
Clinical response to omalizumab in patients with hereditary α-tryptasemiaLybil B. Mendoza Alvarez, Jonathan J. Lyons, Russell Barker et al.|Annals of Allergy Asthma & Immunology|2019Cited by 29